NCT05103735View on ClinicalTrials.gov

Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity

CompletedOBSERVATIONAL

Enrollment

170

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

October 10, 2021

Study Completion Date

October 11, 2021

Conditions

CraniotomySeizuresDexmedetomidinePropofolRemifentanilCerebral TumorNeurophysiology

Interventions

DRUG

Propofol

awake neurosurgery under propofol-remifentanil sedation

Trial Locations (1)

33100

Cristian Deana, Udine

All Listed Sponsors

lead

Azienda Sanitaria-Universitaria Integrata di Udine

OTHER

NCT05103735 - Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity | Biotech Hunter | Biotech Hunter